Search research articles
Contact Us
Filters
Showing results (201-210 of 356) with videos related to
Page
of 36
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 1, 1990
Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action
J W Funder, P T Pearce, K Myles, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1996
Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women
K Sudhir, G L Jennings, J W Funder, et al.
Molecular and Cellular Endocrinology
|
September 1, 1992
Evidence that the stimulation by arginine vasopressin of the release of adrenocorticotropin from the ovine anterior pituitary involves the activation of protein kinase C
J P Liu, D Engler, J W Funder, et al.
Journal of Steroid Biochemistry
|
May 1, 1976
16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats
P J Fuller, L Pressley, W R Adam, et al.
Endocrinology
|
December 1, 1990
Characterization of 11 beta-hydroxysteroid dehydrogenase gene expression: identification of multiple unique forms of messenger ribonucleic acid in the rat kidney
Z Krozowski, S Stuchbery, P White, et al.
The Journal of Clinical Investigation
|
April 1, 1994
Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa
J P Liu, I J Clarke, J W Funder, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1983
Cyproheptadine and mineralocorticoid effector mechanisms
D Armanini, G J Goland, W R Adam, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
January 1, 1982
Glucocorticoid induction of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo
F A Mendelsohn, C J Lloyd, C Kachel, et al.
Endocrinology
|
November 1, 1980
19-nor analogs of adrenal steroids: mineralocorticoid and glucocorticoid receptor activity
K N Wynne, J Mercer, J R Stockigt, et al.
Journal of Steroid Biochemistry
|
December 1, 1989
Immunocytochemical demonstration of mineralocorticoid receptors in rat and human kidney
S E Rundle, A I Smith, D Stockman, et al.
Page
of 36
Search research articles
Search
Showing results (201-210 of 356) with videos related to
Sort By:
Page
of 36
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 1, 1990
Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action
J W Funder, P T Pearce, K Myles, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1996
Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women
K Sudhir, G L Jennings, J W Funder, et al.
Molecular and Cellular Endocrinology
|
September 1, 1992
Evidence that the stimulation by arginine vasopressin of the release of adrenocorticotropin from the ovine anterior pituitary involves the activation of protein kinase C
J P Liu, D Engler, J W Funder, et al.
Journal of Steroid Biochemistry
|
May 1, 1976
16alpha, 18-Dihydroxydeoxycorticosterone and the binding of aldosterone to mineralocorticoid receptors in kidney of adrenalectomized rats
P J Fuller, L Pressley, W R Adam, et al.
Endocrinology
|
December 1, 1990
Characterization of 11 beta-hydroxysteroid dehydrogenase gene expression: identification of multiple unique forms of messenger ribonucleic acid in the rat kidney
Z Krozowski, S Stuchbery, P White, et al.
The Journal of Clinical Investigation
|
April 1, 1994
Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa
J P Liu, I J Clarke, J W Funder, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 1983
Cyproheptadine and mineralocorticoid effector mechanisms
D Armanini, G J Goland, W R Adam, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
January 1, 1982
Glucocorticoid induction of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo
F A Mendelsohn, C J Lloyd, C Kachel, et al.
Endocrinology
|
November 1, 1980
19-nor analogs of adrenal steroids: mineralocorticoid and glucocorticoid receptor activity
K N Wynne, J Mercer, J R Stockigt, et al.
Journal of Steroid Biochemistry
|
December 1, 1989
Immunocytochemical demonstration of mineralocorticoid receptors in rat and human kidney
S E Rundle, A I Smith, D Stockman, et al.
Page
of 36